Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus ointment 0.1% and 0.03%

Tacrolimus · Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tacrolimus ointment 0.1% and 0.03%, covering 2014-09-01 to 2014-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis [Phase 3]

See pricing